Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Fauzia Parween"'
Publikováno v:
PLoS ONE, Vol 16, Iss 10 (2021)
Serum Paraoxonase 2 (PON2) level is a potential biomarker owing to its association with a number of pathophysiological conditions such as atherosclerosis and cardiovascular disease. Since cholinergic deficiency is closely linked with Alzheimer’s di
Externí odkaz:
https://doaj.org/article/5223da74d4b046cbad93d5bbb5e1d233
Autor:
Roshan Kumar Dutta, Fauzia Parween, Md Summon Hossain, Nidhi Dhama, Parmanand Pandey, Rinkoo Devi Gupta
Publikováno v:
PLoS ONE, Vol 14, Iss 6, p e0218629 (2019)
Senescence Marker Protein (SMP30) is a metalloenzyme that shows lactonase activity in the ascorbic acid (AA) biosynthesis pathway in non-primate mammals such as a mouse. However, AA biosynthesis does not occur in the primates including humans. Severa
Externí odkaz:
https://doaj.org/article/e8a78806effe432ca7e49d3ca8009ea6
Publikováno v:
NeuroToxicology. 93:60-70
Organophosphate (OP) compounds are frequently linked to both chronic and acute forms of nervous system disorders. Chlorpyrifos (CPF) and parathion (PA) are two of the most widely used OP insecticides throughout the world. These compounds are acetylch
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c45b1ea5f6f0dc9efbf79b84da6e622e
https://doi.org/10.1016/j.neuro.2022.08.016
https://doi.org/10.1016/j.neuro.2022.08.016
Paraoxonase 2 (PON2) is considered as a potential anti-biofilm agent due to the highest lactonase activity among the PON family members implicating quorum quenching in gram-negative bacteria. However, PON2 is expressed mostly in insoluble fractions i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0256f32f0c5a2813ffe1859fcb93a4a1
Autor:
Fauzia Parween, Rinkoo Devi Gupta
Publikováno v:
Journal of Biosciences
Paraoxonase 2 (PON2) is a ubiquitously expressed intracellular enzyme that is known to have a protective role from oxidative stress. Clinical studies have also demonstrated the significance of PON2 in the manifestation of cardiovascular and several o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::19940bab90fa08a426d49c0d365f862b
http://europepmc.org/articles/PMC8721187
http://europepmc.org/articles/PMC8721187
Autor:
Parmanand Pandey, Nidhi Dhama, Roshan Kumar Dutta, Fauzia Parween, Md. Summon Hossain, Rinkoo D. Gupta
Publikováno v:
PLoS ONE
PLoS ONE, Vol 14, Iss 6, p e0218629 (2019)
PLoS ONE, Vol 14, Iss 6, p e0218629 (2019)
Senescence Marker Protein (SMP30) is a metalloenzyme that shows lactonase activity in the ascorbic acid (AA) biosynthesis pathway in non-primate mammals such as a mouse. However, AA biosynthesis does not occur in the primates including humans. Severa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b31c46cb236088d84961dc08acdea357
https://pubmed.ncbi.nlm.nih.gov/31220150
https://pubmed.ncbi.nlm.nih.gov/31220150